Wnt/beta-catenin

Class

small molecule

Notes

original target text: Wnt/beta-catenin pathway inhibitor

The Wnt/beta-catenin pathway is an ancient signaling system that controls how cells decide to proliferate, differentiate, or maintain a stem-like state. Extracellular Wnt proteins bind receptors on the cell surface, triggering a cascade that prevents the destruction of beta-catenin, a protein that then accumulates and moves into the nucleus, where it partners with transcription factors to switch on genes involved in cell division and survival. In healthy tissue this pathway is tightly regulated and important for tissue renewal, such as in the gut lining and blood-forming stem cells. In many cancers, mutations or other abnormalities cause the pathway to stay switched on inappropriately, giving malignant cells a growth and survival advantage and sometimes helping them evade cell death. Wnt/beta-catenin inhibitors are designed to block this abnormal signaling, aiming to shrink the pool of proliferating or self-renewing tumor cells, including subpopulations thought to resist conventional chemotherapy. Because the pathway is also active in some normal adult tissues, drugs targeting it carry an inherent risk of disrupting normal tissue maintenance, which is a central consideration in developing this mechanism. This pathway matters broadly across oncology, particularly in cancers with a strong stem-cell-like component.